Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.76 USD
−16.35 M USD
109.99 K USD
5.19 M
About Lipocine Inc.
Sector
CEO
Mahesh V. Patel
Headquarters
Salt Lake City
Website
Founded
2011
FIGI
BBG0029L1X69
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LPCN is 4.90 USD — it has increased by 2.18% in the past 24 hours. Watch Lipocine Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lipocine Inc. stocks are traded under the ticker LPCN.
LPCN stock has fallen by −5.63% compared to the previous week, the month change is a −12.81% fall, over the last year Lipocine Inc. has showed a 97.58% increase.
We've gathered analysts' opinions on Lipocine Inc. future price: according to them, LPCN price has a max estimate of 33.00 USD and a min estimate of 10.00 USD. Watch LPCN chart and read a more detailed Lipocine Inc. stock forecast: see what analysts think of Lipocine Inc. and suggest that you do with its stocks.
LPCN reached its all-time high on Aug 28, 2013 with the price of 340.14 USD, and its all-time low was 2.31 USD and was reached on Oct 30, 2023. View more price dynamics on LPCN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LPCN stock is 4.71% volatile and has beta coefficient of 0.34. Track Lipocine Inc. stock price on the chart and check out the list of the most volatile stocks — is Lipocine Inc. there?
Today Lipocine Inc. has the market capitalization of 26.74 M, it has increased by 2.25% over the last week.
Yes, you can track Lipocine Inc. financials in yearly and quarterly reports right on TradingView.
Lipocine Inc. is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
LPCN earnings for the last quarter are −0.44 USD per share, whereas the estimation was −0.48 USD resulting in a 9.28% surprise. The estimated earnings for the next quarter are −0.37 USD per share. See more details about Lipocine Inc. earnings.
Lipocine Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 129.50 K USD. In the next quarter, revenue is expected to reach 1.35 M USD.
LPCN net income for the last quarter is −2.22 M USD, while the quarter before that showed −3.07 M USD of net income which accounts for 27.69% change. Track more Lipocine Inc. financial stats to get the full picture.
No, LPCN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 17.00 employees. See our rating of the largest employees — is Lipocine Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lipocine Inc. EBITDA is −5.42 M USD, and current EBITDA margin is −13.58 K%. See more stats in Lipocine Inc. financial statements.
Like other stocks, LPCN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lipocine Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lipocine Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lipocine Inc. stock shows the sell signal. See more of Lipocine Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.